CL2009001447A1 - Metodo para preparar una composicion farmaceutica que comprende a) recubrir particulas inertes con una composicion que comprende ciclobenzaprina y un solvente para formar perlas de liberacion inmediata (ir), b) recubrir las perlas ir con una composicion de farmaco de liberacion sostenida (er) que comprende un polimero insoluble en agua y c) curar las perlas er a 60°c por 4-12 hrs. a una atmosfera con un punto de rocio que varia entre 5-20°c. - Google Patents
Metodo para preparar una composicion farmaceutica que comprende a) recubrir particulas inertes con una composicion que comprende ciclobenzaprina y un solvente para formar perlas de liberacion inmediata (ir), b) recubrir las perlas ir con una composicion de farmaco de liberacion sostenida (er) que comprende un polimero insoluble en agua y c) curar las perlas er a 60°c por 4-12 hrs. a una atmosfera con un punto de rocio que varia entre 5-20°c.Info
- Publication number
- CL2009001447A1 CL2009001447A1 CL2009001447A CL2009001447A CL2009001447A1 CL 2009001447 A1 CL2009001447 A1 CL 2009001447A1 CL 2009001447 A CL2009001447 A CL 2009001447A CL 2009001447 A CL2009001447 A CL 2009001447A CL 2009001447 A1 CL2009001447 A1 CL 2009001447A1
- Authority
- CL
- Chile
- Prior art keywords
- beads
- composition
- coating
- cyclobenzaprine
- preparing
- Prior art date
Links
- 239000011324 bead Substances 0.000 title abstract 5
- 239000011248 coating agent Substances 0.000 title abstract 3
- 238000000576 coating method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- JURKNVYFZMSNLP-UHFFFAOYSA-N cyclobenzaprine Chemical compound C1=CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 JURKNVYFZMSNLP-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003572 cyclobenzaprine Drugs 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000002245 particle Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 title abstract 2
- 239000002904 solvent Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 title 1
- 238000013268 sustained release Methods 0.000 title 1
- 239000012730 sustained-release form Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Método para preparar una composición farmacéutica que comprende recubrir partículas inertes con una composición que comprende ciclobenzaprina y un solvente farmacéuticamente aceptable, para formar perlas ir, que luego se recubren con un polímero farmacéuticamente aceptable insoluble en agua, para formar perlas er.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7446408P | 2008-06-20 | 2008-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2009001447A1 true CL2009001447A1 (es) | 2009-08-21 |
Family
ID=41434443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2009001447A CL2009001447A1 (es) | 2008-06-20 | 2009-06-19 | Metodo para preparar una composicion farmaceutica que comprende a) recubrir particulas inertes con una composicion que comprende ciclobenzaprina y un solvente para formar perlas de liberacion inmediata (ir), b) recubrir las perlas ir con una composicion de farmaco de liberacion sostenida (er) que comprende un polimero insoluble en agua y c) curar las perlas er a 60°c por 4-12 hrs. a una atmosfera con un punto de rocio que varia entre 5-20°c. |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US20090148532A1 (es) |
| EP (1) | EP2303020B1 (es) |
| JP (1) | JP5636364B2 (es) |
| KR (1) | KR101451823B1 (es) |
| CN (2) | CN102065691A (es) |
| AR (2) | AR072267A1 (es) |
| AU (1) | AU2009259993B2 (es) |
| BR (1) | BRPI0914225B1 (es) |
| CA (1) | CA2727935C (es) |
| CL (1) | CL2009001447A1 (es) |
| CO (1) | CO6300903A2 (es) |
| CR (1) | CR11864A (es) |
| CY (1) | CY1118878T1 (es) |
| DK (1) | DK2303020T3 (es) |
| ES (1) | ES2625485T3 (es) |
| HU (1) | HUE032182T2 (es) |
| IL (1) | IL209997A0 (es) |
| MX (1) | MX2010013760A (es) |
| MY (2) | MY153712A (es) |
| NZ (1) | NZ589856A (es) |
| PL (1) | PL2303020T3 (es) |
| PT (1) | PT2303020T (es) |
| RU (1) | RU2540494C2 (es) |
| SG (1) | SG193816A1 (es) |
| TW (2) | TW201503915A (es) |
| UY (1) | UY31928A (es) |
| WO (1) | WO2009155426A1 (es) |
| ZA (2) | ZA201009083B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
| WO2010133961A1 (en) * | 2009-05-22 | 2010-11-25 | Inventia Healthcare Private Limited | Extended release compositions of cyclobenzaprine |
| EP2501234B1 (en) * | 2009-11-20 | 2017-09-13 | Tonix Pharma Holdings Limited | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine |
| US20110319389A1 (en) | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
| US11998516B2 (en) | 2011-03-07 | 2024-06-04 | Tonix Pharma Holdings Limited | Methods and compositions for treating depression using cyclobenzaprine |
| WO2013158638A1 (en) * | 2012-04-17 | 2013-10-24 | Mylan, Inc. | Stable dosage forms of skeletal muscle relaxants with extended release coating |
| AU2013274003B2 (en) * | 2012-06-15 | 2018-07-05 | Tonix Pharma Limited | Compositions and methods for transmucosal absorption |
| MX370021B (es) | 2013-03-15 | 2019-11-28 | Tonix Pharmaceuticals Inc | Formulaciones eutécticas de clorhidrato de ciclobenzaprina y de clorhidrato de amitriptilina. |
| WO2016044796A1 (en) | 2014-09-18 | 2016-03-24 | Seth Lederman | Eutectic formulations of cyclobenzaprine hydrochloride |
| EA201992116A1 (ru) * | 2017-03-08 | 2020-01-29 | СИНРКС ФАРМА, ЭлЭлСи | Фармацевтические составы флороглюцинола и триметилфлороглюцинола |
| BR112020011345A2 (pt) | 2017-12-11 | 2020-11-17 | Tonix Pharma Holdings Limited | tratamento com ciclobenzaprina para agitação, psicose e declínio cognitivo na demência e condições neurodegenerativas |
| CN109381446A (zh) * | 2018-11-26 | 2019-02-26 | 正大制药（青岛）有限公司 | 一种盐酸环苯扎林缓释胶囊 |
| CN111374942B (zh) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | 一种甾体类肌松药注射液及其制备方法 |
| CN114432266B (zh) * | 2021-12-23 | 2023-03-10 | 南通联亚药业股份有限公司 | 一种稳定的盐酸环苯扎林缓释胶囊 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3882246A (en) | 1971-05-21 | 1975-05-06 | Merck & Co Inc | Treatment of skeletal muscle disorders with cyclobenzaprine |
| US4337582A (en) * | 1980-09-30 | 1982-07-06 | Airco, Inc. | Methods for controlling vapor concentrations in an atmosphere |
| US4685918A (en) | 1985-02-01 | 1987-08-11 | Merck & Co., Inc. | Lipid osmotic pump |
| US5047258A (en) | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
| WO2001019901A2 (en) * | 1999-09-14 | 2001-03-22 | Smithkline Beecham Corporation | Process for making aqueous coated beadlets |
| US6576702B2 (en) | 2000-07-20 | 2003-06-10 | Noveon Ip Holdings Corp. | Plasticized waterborne polyurethane dispersions and manufacturing process |
| AU2003224794A1 (en) | 2002-03-29 | 2003-10-13 | Alza Corporation | Volume efficient controlled release dosage form |
| GB0219024D0 (en) * | 2002-08-15 | 2002-09-25 | Pfizer Ltd | Synergistic combinations |
| GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
| US20050158383A1 (en) | 2003-10-21 | 2005-07-21 | Garth Boehm | Quetiapine formulations |
| US7387793B2 (en) * | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
| US20060039975A1 (en) | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
| US20060263429A1 (en) * | 2005-05-20 | 2006-11-23 | Hengsheng Feng | Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof |
| WO2007110875A1 (en) * | 2006-03-24 | 2007-10-04 | Panacea Biotec Ltd. | Antibiotic compositions of modified release and process of production thereof |
| US20090148532A1 (en) | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
-
2008
- 2008-12-08 US US12/314,290 patent/US20090148532A1/en not_active Abandoned
-
2009
- 2009-06-18 EP EP09767735.5A patent/EP2303020B1/en active Active
- 2009-06-18 MY MYPI2010005973A patent/MY153712A/en unknown
- 2009-06-18 KR KR1020107028313A patent/KR101451823B1/ko active Active
- 2009-06-18 JP JP2011514809A patent/JP5636364B2/ja not_active Expired - Fee Related
- 2009-06-18 HU HUE09767735A patent/HUE032182T2/en unknown
- 2009-06-18 SG SG2013063995A patent/SG193816A1/en unknown
- 2009-06-18 BR BRPI0914225-8A patent/BRPI0914225B1/pt active IP Right Grant
- 2009-06-18 WO PCT/US2009/047807 patent/WO2009155426A1/en not_active Ceased
- 2009-06-18 PT PT97677355T patent/PT2303020T/pt unknown
- 2009-06-18 PL PL09767735T patent/PL2303020T3/pl unknown
- 2009-06-18 CN CN200980123134XA patent/CN102065691A/zh active Pending
- 2009-06-18 RU RU2011101918/15A patent/RU2540494C2/ru active
- 2009-06-18 US US12/487,339 patent/US8137734B2/en not_active Expired - Fee Related
- 2009-06-18 MY MYPI2014001784A patent/MY173408A/en unknown
- 2009-06-18 AU AU2009259993A patent/AU2009259993B2/en not_active Ceased
- 2009-06-18 CA CA2727935A patent/CA2727935C/en active Active
- 2009-06-18 ES ES09767735.5T patent/ES2625485T3/es active Active
- 2009-06-18 MX MX2010013760A patent/MX2010013760A/es active IP Right Grant
- 2009-06-18 DK DK09767735.5T patent/DK2303020T3/en active
- 2009-06-18 NZ NZ589856A patent/NZ589856A/en not_active IP Right Cessation
- 2009-06-18 CN CN201710064209.8A patent/CN106860430A/zh active Pending
- 2009-06-19 TW TW103134301A patent/TW201503915A/zh unknown
- 2009-06-19 AR ARP090102268A patent/AR072267A1/es unknown
- 2009-06-19 TW TW098120716A patent/TWI458480B/zh not_active IP Right Cessation
- 2009-06-19 CL CL2009001447A patent/CL2009001447A1/es unknown
- 2009-06-22 UY UY0001031928A patent/UY31928A/es not_active Application Discontinuation
-
2010
- 2010-12-13 CO CO10156300A patent/CO6300903A2/es not_active Application Discontinuation
- 2010-12-14 IL IL209997A patent/IL209997A0/en active IP Right Grant
- 2010-12-17 ZA ZA2010/09083A patent/ZA201009083B/en unknown
- 2010-12-21 CR CR11864A patent/CR11864A/es unknown
-
2011
- 2011-12-23 ZA ZA2011/09534A patent/ZA201109534B/en unknown
-
2012
- 2012-02-13 US US13/371,967 patent/US20120196028A1/en not_active Abandoned
-
2017
- 2017-04-26 CY CY20171100470T patent/CY1118878T1/el unknown
-
2018
- 2018-11-12 AR ARP180103296A patent/AR113877A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2009001447A1 (es) | Metodo para preparar una composicion farmaceutica que comprende a) recubrir particulas inertes con una composicion que comprende ciclobenzaprina y un solvente para formar perlas de liberacion inmediata (ir), b) recubrir las perlas ir con una composicion de farmaco de liberacion sostenida (er) que comprende un polimero insoluble en agua y c) curar las perlas er a 60°c por 4-12 hrs. a una atmosfera con un punto de rocio que varia entre 5-20°c. | |
| CY2019021I2 (el) | Συστημα χορηγησης φαρμακων για τη χορηγηση πτωχως υδατοδιαλυτων φαρμακευτικως ενεργων ουσιων | |
| AR082688A1 (es) | Uso de aglomerantes para preparar formulaciones estables al almacenamiento | |
| WO2013151576A3 (en) | Delivery system for segmented scaffolds | |
| CL2015000544A1 (es) | Una composicion farmaceutica que comprende regorafenib y al menos un excipiente farmaceuticamente aceptable, en el que la composicion esta recubierta por un recubrimiento que comprende un polimero basado en alcohol polivinilico; y su procedimiento de preparacion. | |
| MX2010004789A (es) | Sistema de liberacion transdermica para hormonas y esteroides. | |
| EP2251038A4 (en) | SOLID DISPERSION, PHARMACEUTICAL COMPOSITIONS THEREFOR AND METHOD FOR THE PRODUCTION THEREOF | |
| WO2009063222A3 (en) | Solid compositions | |
| CL2013001942A1 (es) | Composicion de suministro de farmaco biodegradable que comprende a) un copolimero de tres bloques biodegradable, b) un copolimero de dos bloques biodegradable, y c) cuando menos un principio farmaceuticamente activo; metodo para su preparacion: y su uso. | |
| WO2006097558A3 (es) | Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas | |
| EP2143446A4 (en) | HYBRID GEL WITH CHEMICALLY NETWORKED HYALURONIC ACID DERIVATIVE AND MEDICAMENT THEREFOR | |
| MX2015000114A (es) | Composiciones farmaceuticas disuasivas de abuso de liberacion prolongada. | |
| BRPI0817725A2 (pt) | composoção, método para concentrar poliplexos quitosano-ácido nucleico, dispersão concentrada de poliplexos quitosano-ácido nucleico, composoção farmacêutica, e, método para laterar o diâmentro de poliplexos quitosano-ácido nucleico | |
| WO2010010256A3 (fr) | Medicament appetissant a administration orale sous forme solide | |
| BRPI1014881A2 (pt) | película antirreflexo, método para manufaturar película antirreflexo, e aparelho de exibição." | |
| WO2008152115A3 (en) | Drug-releasing polyelectrolyte coating, method for forming a drug-releasing polyelectrolyte coating, and implantable device | |
| WO2010005732A8 (en) | Composition and method of preparation of release systems for constant (zero-order) release of active agents | |
| PH12015502556A1 (en) | Modified release formulation | |
| EP4216937A4 (en) | PHARMACEUTICAL FORMULATION WITH EXTENDED RELEASE | |
| WO2014016671A3 (en) | Formulations and methods of manufacturing formulations for use in colonic evacuation | |
| WO2008152398A3 (en) | Formulations for inhalation | |
| JP2015508411A5 (es) | ||
| DK1820506T3 (da) | Dipyridamol-formuleringer med forlænget frigivelse og fremgangsmåde til fremstilling heraf | |
| WO2009028598A1 (ja) | 徐放性製剤及びその製造方法 | |
| WO2011056702A3 (en) | Fast dissolving/disintegrating coating compositions |